Pharmaceuticals

Autoimmune Drugs Market size to grow by USD 29,314.5 million between 2022 and 2027; AbbVie Inc., and AdvaCare Pharma among others, identified as key vendors

by

NEW YORK, May 19, 2023 /PRNewswire/ — The autoimmune drugs market size is set to grow by USD 29314.5 million between 2022 and 2027 and register a CAGR of 6.39%, according to Technavio’s latest market research report. With a focus on identifying dominant industry influencers, Technavio’s reports present a detailed study by way of synthesis, and summation … Read more

Featuring CVS, Sanofi, Walgreens, Albertsons Companies, GlaxoSmithKline & More

by

DUBLIN, May 19, 2023 /PRNewswire/ — The “Global Pharmacy Retail Market Outlook to 2027” report has been added to  ResearchAndMarkets.com’s offering. The report provides a comprehensive analysis of the potential of the Pharmacy Retail industry Globally. The report covers an overview and genesis of the industry, and market size in terms of revenue generated. Its market … Read more

Development of Smart Hospital Gowns Presents Opportunities

by

DUBLIN, May 19, 2023 /PRNewswire/ — The “Global Hospital Gowns Market 2023-2030” report has been added to  ResearchAndMarkets.com’s offering. As per report estimates, the global hospital gowns market will progress with a CAGR of 11.83% in the forecasted years from 2023 to 2030. The rise in the prevalence of healthcare-associated infections (HAIs) and the increasing … Read more

Des résultats positifs ressortent de l’analyse intermédiaire de l’essai de phase II ‘GEN-001’ Plus avelumab (Bavencio®)

by

SÉOUL, Corée du Sud, 19 mai 2023 /PRNewswire/ — Genome & Company (PDG : Pae, Jisoo), un leader mondial dans le développement de thérapies du microbiome, a annoncé que cet essai de phase II (NCT05419362) se poursuivrait sans modifications pour passer à la deuxième étape, sur la base du résultat positif de l’analyse intermédiaire. La combinaison … Read more

Mães revelam como o autocuidado é essencial para o bem-estar e a qualidade de vida

by

Mulheres que utilizaram produtos Rennova contam suas experiências positivas após procedimentos estéticos minimamente invasivos SÃO PAULO, 19 de maio de 2023 /PRNewswire/ — O envelhecimento faz parte da vida e não há como fugir dele. No entanto, com a ajuda da ciência, é possível suavizar os sinais do tempo com procedimentos estéticos minimamente invasivos. A … Read more

FDA Roundup: May 19, 2023

by

SILVER SPRING, Md., May 19, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that the National Academies of Sciences, Engineering, and Medicine (NASEM) will conduct an independent study on challenges in supply, market competition, and regulation of infant … Read more

FDA Clears New Insulin Pump and Algorithm-Based Software to Support Enhanced Automatic Insulin Delivery

by

Agency Continues to Support Innovation of Next-Generation Technology in Diabetes Management SILVER SPRING, Md., May 19, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with type 1 diabetes. These two devices, along with … Read more

In-depth Examination of the Major Technologies, Encompassing 50 Technologies in 9 Categories

by

DUBLIN, May 19, 2023 /PRNewswire/ — The “Lab Instrumentation Markets for Pharmaceuticals and Biopharmaceuticals” report has been added to  ResearchAndMarkets.com’s offering. Lab Instrumentation Markets for Pharmaceuticals and Biopharmaceuticals is an in-depth examination of the major technologies used in the pharma/bio sector, encompassing 50 technologies in 9 categories. The report examines historical growth and provides forecasts for … Read more

FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa

by

SILVER SPRING, Md., May 19, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene. … Read more

Amendment to BAA Outlines New BARDA Funding Opportunities for Next-generation COVID-19 Vaccines, Monoclonal Antibodies, and Antivirals

by

By Laura Powell, Managing Consultant and Eric Jia-Sobota, Founder CHARLESTON, S.C. , May 19, 2023 /PRNewswire/ — In the latest amendment to its Broad Agency Announcement (BAA), BARDA (Biomedical Advanced Research and Development Authority) is seeking proposals for the development of cost-effective and adaptable therapeutic platforms to treat viral infections, as well as next-generation COVID-19 vaccines. … Read more